To target NSCs in the adult brain, researchers utilized Cre recombinase-expressing adenovirus injected into the SVZ of mutant mice with conditional Tp53, Pten, and Nf1 or Rb knockout, which resulted in the development of GBM (42, 43). The gene discussed is RB1; the disease is glioblastoma.